Literature DB >> 15579278

Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progression.

Michael R Nonnemacher1, Bryan P Irish, Yujie Liu, David Mauger, Brian Wigdahl.   

Abstract

Basal and activated human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) activity, and in return, viral replication is partly dependent on interactions of the G/C box array with the Sp family of transcription factors. Analysis of LTR Sp binding site sequence variants revealed a C-to-T change at position 5 within Sp site III that increased in frequency and a 5T mutation within Sp site II, which decreased in frequency during the course of HIV disease. These results suggest LTR Sp binding site sequence variants may prove useful as viral molecular markers indicative of progressive HIV-1-induced disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579278     DOI: 10.1016/j.jneuroim.2004.08.021

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  22 in total

1.  Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.

Authors:  Yujie Liu; Michael R Nonnemacher; Devin L Stauff; Luna Li; Anupam Banerjee; Bryan Irish; Evelyn Kilareski; Nirmala Rajagopalan; Joyce B Suchitra; Zafar K Khan; Udaykumar Ranga; Brian Wigdahl
Journal:  Biomed Pharmacother       Date:  2010-09-25       Impact factor: 6.529

Review 2.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

Review 3.  HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.

Authors:  Melissa J Churchill; Daniel J Cowley; Steve L Wesselingh; Paul R Gorry; Lachlan R Gray
Journal:  J Neurovirol       Date:  2014-07-25       Impact factor: 2.643

Review 4.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

5.  Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy.

Authors:  Robert W Link; Michael R Nonnemacher; Brian Wigdahl; Will Dampier
Journal:  CRISPR J       Date:  2018-08

6.  Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment.

Authors:  Luna Li; Benjamas Aiamkitsumrit; Vanessa Pirrone; Michael R Nonnemacher; Adam Wojno; Shendra Passic; Katherine Flaig; Evelyn Kilareski; Brandon Blakey; Jade Ku; Nirzari Parikh; Rushabh Shah; Julio Martin-Garcia; Brian Moldover; Laila Servance; David Downie; Sharon Lewis; Jeffrey M Jacobson; Dennis Kolson; Brian Wigdahl
Journal:  J Neurovirol       Date:  2011-01-12       Impact factor: 2.643

Review 7.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

8.  Impact of Tat Genetic Variation on HIV-1 Disease.

Authors:  Luna Li; Satinder Dahiya; Sandhya Kortagere; Benjamas Aiamkitsumrit; David Cunningham; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virol       Date:  2012-07-30

Review 9.  Molecular mechanisms of HIV-1 associated neurodegeneration.

Authors:  Hakan Ozdener
Journal:  J Biosci       Date:  2005-06       Impact factor: 2.795

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.